Mullerian Mixed Tumor of Ovary
1 clinical trials · Condition
◉ Watch Mullerian Mixed Tumor of Ovary
| Record | Firm | Date |
|---|---|---|
| Protocol to Allow Continued Access of Ficlatuzumab to P05538 Patient (NCT02090127) | AVEO Pharmaceuticals, Inc. |
Track Mullerian Mixed Tumor of Ovary automatically
Every clearance here is in the API, with alerts when new ones post.